SPAC Daily: SCVX Throws in the Towel

by | Jul 27, 2022

SCVX Corporation (SCVCX) was set to vote today on an extension of its SPAC deadline to give them more time to find a deal partner. The terms were for 9 months though they, interestingly, were not providing any compensation (addition to its trust) in order to get the extension. The result? The SPAC is going to liquidate instead.

With SPAC yields still elevated and deals scarce to come by, a simple time value of money lesson would tell you that common shareholders would not stick around for that. The liquidation train is definitely coming…

Recent SPACs to Liquidate

Source: Boardroom Alpha

Elsewhere in SPACs

  • Healthcare Sciences Acquisition Corp. (HSAQ) extension was approved to 11/6/2022. No word on redemptions
  • Software Acquisition Corp. II (SWAG) set a 8/22 vote date for its Nogin deal.
  • Maquia Capital Acquisition Corp. (MAQC) confirmed that it added $0.10 to its trust to extend the SPAC for 3 more months until November. They have no more sponsor exemptions left
  • Waldencast Acquisition Corp. (WALD) announced that its Obagi Skincare & Milk Makeup deal officially closed. The combined company, Waldencast plc, is expected to begin trading on Nasdaq under the ticker WALD tomorrow
  • Duddell Street Acquisition Corp. (DSAC) and FiscalNote deal was approved by shareholders. It is expected to close on Friday and trade as NOTE on Monday Aug-1.

Upcoming SPAC Calendar

Full calendar and SPAC database access here

Today’s SPAC Market Movers

Biggest SPAC Gainers

11.53% ~ $ 10.25 | NLIT – Northern Lights Acquisition Corp. (Announced)
4.37% ~ $ 10.75 | BCAC – Brookline Capital Acquisition Corp. (Pre-Deal)
.61% ~ $ 9.90 | RCAC – Revelstone Capital Acquisition Corp. (Pre-Deal)
.61% ~ $ 9.91 | VBOC – Viscogliosi Brothers Acquisition Corp (Pre-Deal)
.60% ~ $ 10.06 | HNRA – HNR Acquisition Corp (Pre-Deal)
.56% ~ $ 9.95 | ZING – FTAC Zeus Acquisition Corp. (Pre-Deal)
.52% ~ $ 9.72 | NFYS – Enphys Acquisition Corp. (Pre-Deal)
.52% ~ $ 9.75 | IPAX – Inflection Point Acquisition Corp. (Pre-Deal)
.50% ~ $ 10.07 | NETC – Nabors Energy Transition Corp. (Pre-Deal)
.49% ~ $ 10.26 | FST – FAST ACQ CP (Pre-Deal)
.45% ~ $ 10.10 | SWAG – Software Acquisition Group Inc. III (Announced)
.41% ~ $ 9.86 | EBAC – European Biotech Acquisition Corp. (Pre-Deal)
.40% ~ $ 9.92 | MCAC – Monterey Capital Acquisition Corp (Pre-Deal)
.40% ~ $ 9.97 | DRAY – Macondray Capital Acquisition Corp. I (Pre-Deal)
.40% ~ $ 9.98 | RCFA – RCF Acquisition Corp. (Pre-Deal)
.40% ~ $ 10.02 | LIVB – LIV Capital Acquisition Corp. II (Pre-Deal)
.40% ~ $ 10.05 | ASPC – Alpha Capital Acquisition Company (Announced)
.36% ~ $ 30.28 | DWAC – Digital World Acquisition Corp. (Announced)
.36% ~ $ 9.83 | SCAQ – Stratim Cloud Acquisition Corp. (Pre-Deal)
.31% ~ $ 9.66 | DSAC – Duddell Street Acquisition Corp (Announced)

Biggest SPAC Losers

-2.64% ~ $ 9.57 | CHWA – CHW Acquisition Corp (Announced)
-2.14% ~ $ 10.07 | TRON – Corner Growth Acquisition Corp. 2 (Pre-Deal)
-1.46% ~ $ 10.10 | NOVV – Nova Vision Acquisition Corp (Pre-Deal)
-1.05% ~ $ 9.92 | HSAQ – Health Sciences Acquisitions Corporation 2 (Announced)
-.71% ~ $ 9.76 | CCAI – Cascadia Acquisition Corp. (Pre-Deal)
-.60% ~ $ 9.93 | CFFS – CF Acquisition Corp. VII (Pre-Deal)
-.49% ~ $ 10.20 | ACEV – ACE Convergence Acquisition Corp (Announced)
-.40% ~ $ 9.91 | MEKA – MELI Kaszek Pioneer Corp (Pre-Deal)
-.40% ~ $ 9.95 | JUN – Juniper II Corp. (Pre-Deal)
-.40% ~ $ 9.98 | PHYT – Pyrophyte Acquisition Corp. (Pre-Deal)
-.40% ~ $ 10.06 | LJAQ – LIGHTJUMP ACQUISITION CORPORATION (Announced)
-.30% ~ $ 9.85 | CLAA – Colonnade Acquisition Corp. II (Pre-Deal)
-.30% ~ $ 9.89 | FCAX – Fortress Capital Acquisition Corp (Pre-Deal)
-.30% ~ $ 9.96 | SUAC – ShoulderUP Technology Acquisition Corp. (Pre-Deal)
-.30% ~ $ 9.97 | BCSA – Blockchain Coinvestors Acquisition Corp. I (Pre-Deal)
-.30% ~ $ 9.99 | SCMA – Seaport Calibre Materials Acquisition Corp. (Pre-Deal)
-.30% ~ $ 10.07 | VMCA – Valuence Merger Corp. I (Pre-Deal)
-.29% ~ $ 10.23 | FOXW – FoxWayne Enterprises Acquisition Corp. (Pre-Deal)
-.26% ~ $ 9.77 | GFGD – Growth for Good Acquisition Corp (Pre-Deal)
-.25% ~ $ 9.79 | KVSA – Khosla Ventures Acquisition Co (Pre-Deal)

Recent Analysis

Daily SPAC Update – December 10, 2024

Jackson Acquisition II $200M IPO (Jackson I Liquidated). APXI Shareholders Approve Extension w/ 5M Redemptions. HCVI Merger Amendment. SLAMF Vote Adjourned and IVCB Vote Postponed. 

Daily SPAC Update – December 9, 2024

TCHP + Coincheck Deal Approved. GLLI, INAQ, ESHA Shareholders Approve Extensions. DP Cap Acquisition  (DPCS) Dismisses Accountant. SLAM and BRKH Extension Votes.

Daily SPAC Update – December 4, 2024

Global Star (GLST) Extension Approved. APXI Extension Vote Today. ATMC Updates Trust Numbers. LATG Deal Vote Set for Dec 23. ATMV, SHAP, TRON, INAQ Set Extension Votes.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.